PUBLISHER: Grand View Research | PRODUCT CODE: 1888828
PUBLISHER: Grand View Research | PRODUCT CODE: 1888828
The Europe foot and ankle devices market size was estimated at USD 1.01 billion in 2024 and is projected to reach USD 1.72 billion by 2033, growing at a CAGR of 6.1% from 2025 to 2033. The rising incidence of musculoskeletal disorders, including fractures, deformities, and degenerative conditions, coupled with an aging population with expanding orthopedic needs, are driving the European market.
Treatment options are growing owing to developments in minimally invasive surgical methods, innovative implant designs, and the use of 3D-printed patient-specific implants. In October 2024, an AFAS-ESSKA update highlighted Europe's growing role in advancing sports-injury treatment, underscored by its collaboration with MIFAS to support international arthroscopy training. The initiative strengthened Europe's influence in ankle and foot education as faculty from France and Spain led global clinical and cadaveric training programs.
The demand for devices in Europe is largely driven by the increasing prevalence of musculoskeletal disorders. As people age, conditions such as osteoporosis, hallux valgus, and anklebone instability develop more common, necessitating supportive implants and surgical procedures. Hospitals and clinics are expanding their treatment capabilities as part of this demographic trend that emphasizes orthopedic care. In May 2024: European Journal of Pediatrics reported 687,753 foot and ankle events among 416,137 children and young people (CYP) aged 0-18 years in England between 2015 and 2021. Consultations were highest in males aged 10-14 years, with musculoskeletal issues (34%) and unspecified pain (21%) being the most common.
The market is growing due to innovation in surgical techniques such as minimally invasive procedures, arthroscopy, and patient-specific 3D-printed implants. These developments increase surgical accuracy, shorten recovery periods, and improve patient outcomes, increasing the value of procedures to both patients and physicians. Continuous development of high-performance implants, bioactive materials, and modular systems is also driving adoption by enabling more tailored and effective treatment solutions. In May 2024, Stryker supported early European use of its Infinity Total Ankle System with Adaptis and Everlast technology through a UK post-market clinical study, reinforcing its position in the region's advanced reconstruction space.
Europe Foot And Ankle Devices Market Report Segmentation
This report forecasts revenue growth at regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the Europe foot and ankle devices market report based on product, end use, and region: